Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Pharmacokinetics
100%
Primates
100%
Rapid Onset
100%
Duration of Effect
100%
Salvinorin
100%
Hallucinogens
100%
Visual Hallucinations
28%
Physiological Effects
28%
United States
14%
Metabolism
14%
Human Brain
14%
Baboon
14%
Cerebellum
14%
Opioid Receptors
14%
Motor Impairment
14%
Therapeutic Agents
14%
High Concentration
14%
Visual Cortex
14%
Brain Uptake
14%
New Therapeutics
14%
Receptor Targets
14%
Lasting Effect
14%
Two-mode
14%
United Europe
14%
C-11
14%
Acylation
14%
Acetyl Chloride
14%
Biliary System
14%
Positron Emission Tomography Study
14%
Regional Distribution
14%
6-Adult
14%
Kinetic Behavior
14%
Visual-motor
14%
Peripheral Organs
14%
Oaxaca Mexico
14%
Rapid Uptake
14%
Renal System
14%
Mazatecs
14%
Salvia Divinorum
14%
Salvinorin B
14%
Mint Plant
14%
Adult Female
14%
Overall Concentrations
14%
Naloxone Administration
14%
Neuroscience
Hallucinogen
100%
Salvinorin A
100%
Pharmacokinetics
100%
Visual Hallucination
28%
Behavior (Neuroscience)
14%
Naloxone
14%
Visual Cortex
14%
Cerebellum
14%
Salvia Divinorum
14%
Agonist
14%
Positron Emission Tomography
14%
Metabolic Pathway
14%
Receptor
14%
Acylation
14%
Human Brain
14%
Pharmacology, Toxicology and Pharmaceutical Science
Salvinorin A
100%
Pharmacokinetics
100%
Hallucinogen
100%
Carbon 11
42%
Visual Hallucination
28%
Naloxone
14%
Opiate Receptor
14%
Acetic Acid Derivative
14%
Salvia Divinorum
14%
Administered Dose
14%